The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens. [electronic resource]
Producer: 20100617Description: 1272-83 p. digitalISSN:- 1521-4141
- Adjuvants, Immunologic -- pharmacology
- Amino Acid Sequence
- Animals
- Antigen Presentation -- drug effects
- Antigens -- administration & dosage
- Bone Marrow Cells -- immunology
- CD4-Positive T-Lymphocytes -- immunology
- Dendritic Cells -- classification
- Drug Evaluation, Preclinical
- H-2 Antigens -- immunology
- Lipopeptides -- administration & dosage
- Mice
- Mice, Inbred C57BL
- Molecular Sequence Data
- Oligopeptides -- chemical synthesis
- Ovalbumin -- administration & dosage
- Peptide Fragments -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- Spleen -- cytology
- T-Lymphocytes, Cytotoxic -- immunology
- Toll-Like Receptor 2 -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.